Skip to content
Home/Companies/Biotech/Virovet

Virovet

Biotech·Belgium·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Virovet?

Virovet is a Belgian Biotech company, currently owned by Seventure Partners since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Health for Life Capital II · 2020 · VC

Key facts

HQBelgium
SectorBiotech

More from Health for Life Capital II

Other portfolio companies in the same fund.

Nanobiotix
Nanobiotix
Active
BiotechFrance· 2023
RevivBio
RevivBio
Active
BiotechUS· 2023
STRING BIO
String BIO
Active
BiotechInde· 2023
Tubulis
Tubulis
Active
BiotechGermany· 2021
Tibot
Active
HealthcareFrance· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Virovet?

Virovet is currently owned by Seventure Partners, through Health for Life Capital II, since 2023.

When did Seventure Partners acquire Virovet?

Seventure Partners acquired Virovet in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue